PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Cardiovascular Research Institute, University of California San Francisco, 513 Parnassus Avenue, HSE 760, San Francisco, CA, 94143, USA. katherine.wick@ucsf.edu.\', \'Belfast Health and Social Care Trust, Royal Victoria Hospital and Wellcome-Wolfson Institute for Experimental Medicine, Queen\'s University Belfast, Belfast, UK.\', \'Division of Pulmonary, Allergy, and Critical Care Medicine, Stanford University, Stanford, CA, USA.\', \'Center for Acute Respiratory Failure and Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University, New York, NY, USA.\', \'Department of Intensive Care, FHU SEPSIS, and RHU RECORDS, Hôpital Raymond Poincaré (APHP), Garches, France.\', \'Laboratory of Infection & Inflammation, School of Medicine Simone Veil, INSERM, University Versailles Saint Quentin, University Paris Saclay, Garches, France.\', \'Harvard Medical School and Division of Pulmonary, Critical Care, and Sleep Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.\', \'Cardiovascular Research Institute, University of California San Francisco, 513 Parnassus Avenue, HSE 760, San Francisco, CA, 94143, USA.\', \'Departments of Medicine and Anesthesia, University of California, San Francisco, San Francisco, CA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13054-021-03822-z
?:doi
?:hasPublicationType
?:journal
  • Critical care (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 34814925
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Promises and challenges of personalized medicine to guide ARDS therapy.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all